For: | Jiang SW, Lian X, Hu AR, Lu JL, He ZY, Shi XJ, Zhu DD, Wang ZY, Huang GC. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication. World J Gastroenterol 2023; 29(16): 2479-2494 [PMID: 37179582 DOI: 10.3748/wjg.v29.i16.2479] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i16/2479.htm |
Number | Citing Articles |
1 |
Su-Wen Jiang, Ai-Rong Hu. Further understanding of chronic hepatitis B in the indeterminate phase or in the grey zone. World Chinese Journal of Digestology 2024; 32(1): 8 doi: 10.11569/wcjd.v32.i1.8
|
2 |
Ken Lin, Su-Wen Jiang, Ai-Rong Hu. Management of antiviral treatment for chronic hepatitis B patients with high viral load. World Chinese Journal of Digestology 2024; 32(9): 625 doi: 10.11569/wcjd.v32.i9.625
|
3 |
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
|
4 |
Chih-Lin Lin, Jia-Horng Kao. Should we expand treatment initiation criteria for chronic HBV infection: Pros. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000228
|
5 |
Yen-Chun Liu, Wen-Juei Jeng. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?. Current Hepatology Reports 2024; 23(1): 11 doi: 10.1007/s11901-024-00635-w
|
6 |
静 张. Research Progress and Prospects of Chronic Hepatitis B Virus Infection in Gray Zone. Advances in Clinical Medicine 2024; 14(05): 689 doi: 10.12677/acm.2024.1451478
|
7 |
Haiyan Fu, Hongjuan Li, Yingrong Du, Chunyun Liu, Futao Dang, Xuan Zhang, Danqing Xu, Yachao Mao, Li Feng Wang, Yu Luo, Li Liu. Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremia. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102351 doi: 10.1016/j.clinre.2024.102351
|